Live from the NIH registry
Studies recruiting near Santa Barbara right now
Top 25 of 108 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Santa Barbara Cottage Hospital — Santa Barbara, California (1.4 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: Pfizer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: Gilead Sciences
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: NRG Oncology
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: SCRI Development Innovations, LLC
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 1
Interventional 1,394 participants sought
Exelixis Clinical Site #59 — Santa Barbara, California (1.4 mi)
· Sponsor: Exelixis
DoubleTake: Effect of Message Exposure Via a Discrete Choice Experiment With Eye-Tracking on Quit Attempts Among Adults Who Smoke Menthol Cigarettes
Menthol Cigarettes, Smoking Behavior
N/A
Interventional 200 participants sought
University of California, Santa Barbara — Santa Barbara, California (1.4 mi)
· Sponsor: Georgia State University
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Santa Barbara Cottage Hospital — Santa Barbara, California (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
ProACT Post-Approval Study
Stress Urinary Incontinence
N/A
Interventional 145 participants sought
Sutter Health — Santa Barbara, California (1.4 mi)
· Sponsor: Uromedica
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 2
Interventional 310 participants sought
Site 0287 - Ridley Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
Diabetes, Gestational, Pregnancy Complications
Phase 2, Phase 3
Interventional 30 participants sought
Sansum Diabetes Research Institute — Santa Barbara, California (1.4 mi)
· Sponsor: Jaeb Center for Health Research
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Bronchiectasis
Phase 3
Interventional 1,755 participants sought
Ventura County Medical Center — Ventura, California (26.5 mi)
· Sponsor: Boehringer Ingelheim
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast Cancer, Locally Advanced Breast Cancer
Phase 3
Interventional 1,000 participants sought
Clinical Trial Site — Santa Barbara, California (1.4 mi)
· Sponsor: Olema Pharmaceuticals, Inc.
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
UCLA Hematology/Oncology - Santa Barbara — Santa Barbara, California (1.4 mi)
· Sponsor: Pfizer
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 480 participants sought
Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: Janssen Research & Development, LLC
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial Hypertension
Phase 3
Interventional 486 participants sought
Jeffrey S. Sager, MD Medical Corporation — Santa Barbara, California (1.4 mi)
· Sponsor: Inhibikase Therapeutics
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Phase 3
Interventional 1,978 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration, nAMD
Phase 3
Interventional 304 participants sought
California Retina Consultants — Santa Barbara, California (1.4 mi)
· Sponsor: Amgen
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Aortic Stenosis, Coronary Artery Disease
N/A
Interventional 4,000 participants sought
Santa Barbara Cottage Hospital — Santa Barbara, California (1.4 mi)
· Sponsor: University of British Columbia
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 3
Interventional 94 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Prostate Cancer
Phase 2, Phase 3
Interventional 443 participants sought
Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: Novartis Pharmaceuticals
Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)
Parkinson Disease
EARLY/Phase 1
Interventional 50 participants sought
Equilibrium Physical Therapy — Ventura, California (26.5 mi)
· Sponsor: California State University, Northridge